458
Views
4
CrossRef citations to date
0
Altmetric
Research Reports

Genotype-phenotype associations in Danish patients with ocular and oculocutaneous albinism

ORCID Icon, , ORCID Icon, & ORCID Icon
Pages 230-238 | Received 20 Aug 2020, Accepted 10 Jan 2021, Published online: 22 Feb 2021

References

  • Kruijt CC, de Wit GC, Bergen AA, Florijn RJ, Schalij-Delfos NE, van Genderen MM.The phenotypic spectrum of albinism. Ophthalmology. 2018;125(12):1953–60. doi:10.1016/j.ophtha.2018.08.003.
  • Gronskov K, Ek J, Sand A, Scheller R, Bygum A, Brixen K, Brondum-Nielsen K, Rosenberg T. Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism. Invest Ophthalmol Vis Sci. 2009;50(3):1058–64. doi:10.1167/iovs.08-2639.
  • Gainotti S, Mascalzoni D, Bros-Facer V, Petrini C, Floridia G, Roos M, Salvatore M, Taruscio D. Meeting patients’ right to the correct diagnosis: Ongoing international initiatives on undiagnosed rare diseases and ethical and social issues. Int J Environ Res Public Health. 2018;15(10):2072. doi:10.3390/ijerph15102072.
  • Campbell P, Ellingford JM, Parry NRA, Fletcher T, Ramsden SC, Gale T, Hall G, Smith K, Kasperaviciute D, Chris Lloyd ET, et al. Clinical and genetic variability in children with partial albinism. Sci Rep. 2019;9(1):16576. doi:10.1038/s41598-019-51768-8.
  • Montoliu L, Gronskov K, Wei A-H, Martinez-Garcia M, Fernandez A, Arveiler B, Morice-Picard F, Riazuddin S, Suzuki T, Ahmed ZM, et al. Increasing the complexity: new genes and new types of albinism. Pigment Cell Melanoma Res. 2014;27(1):11–18. doi:10.1111/pcmr.12167.
  • Marçon CR, Maia M.Albinism: epidemiology, genetics, cutaneous characterization, psychosocial factors. An Bras Dermatol. 2019;94(5):503–20. doi:10.1016/j.abd.2019.09.023.
  • King RA, Pietsch J, Fryer JP, Savage S, Brott MJ, Russell-Eggitt I, Summers CG, Oetting WS. Tyrosinase gene mutations in oculocutaneous albinism1 (OCA1): definition of the phenotype. Hum Genet. 2003;113(6):502–13. doi:10.1007/s00439-003-0998-1.
  • Barton DE, Kwon BS, Francke U.Human tyrosinase gene, mapped to chromosome 11 (q14 → q21), defines second region of homology with mouse chromosome 7. Genomics. 1988;3(1):17–24. doi:10.1016/0888-7543(88)90153-X.
  • Ramsay M, Colman MA, Stevens G, Zwane E, Kromberg J, Farrall M, Jenkins T. The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12. Am J Hum Genet 1992;51:879–84.
  • Boissy RE, Zhao H, Oetting WS, Austin LM, Wildenberg SC, Boissy YL, Zhao Y, Sturm RA, Hearing VJ, King RA, et al. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as “OCA3”. Am J Hum Genet 1996;58:1145–56.
  • Newton JM, Cohen-Barak O, Hagiwara N, Gardner JM, Davisson MT, King RA, Brilliant MH. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4. Am J Hum Genet. 2001;69(5):981–88. doi:10.1086/324340.
  • Kausar T, Bhatti MA, Ali M, Shaikh RS, Ahmed ZM.OCA5, a novel locus for non-syndromic oculocutaneous albinism, maps to chromosome 4q24. Clin Genet. 2013;84(1):91–93. doi:10.1111/cge.12019.
  • Lamason RL, Mohideen MA, Mest JR, Wong AC, Norton HL, Aros MC, Jurynec MJ, Mao X, Humphreville VR, Humbert JE, et al. SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. Science. 2005;310(5755):1782–86. doi:10.1126/science.1116238.
  • Gronskov K, Dooley CM, Ostergaard E, Kelsh RN, Hansen L, Levesque MP, Vilhelmsen K, Møllgård K, Stemple D, Rosenberg T, et al. Mutations in c10orf11, a melanocyte-differentiation gene, cause autosomal-recessive albinism. Am J Hum Genet. 2013;92(3):415–21. doi:10.1016/j.ajhg.2013.01.006.
  • Bassi MT, Schiaffino MV, Renieri A, De Nigris F, Galli L, Bruttini M, Gebbia M, Bergen AAB, Lewis RA, Ballabio A, et al. Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome. Nat Genet. 1995;10(1):13–19. doi:10.1038/ng0595-13.
  • Huizing M, Malicdan MCV, Wang JA, Pri-Chen H, Hess RA, Fischer R, O'Brien KJ, Merideth MA, Gahl WA, Gochuico BR. Hermansky-pudlak syndrome: Mutation update. Hum Mutat. 2020;41(3):543–80. doi:10.1002/humu.23968.
  • Toro C, Nicoli ER, Malicdan MC, Adams DR, Introne WJ. Chediak-higashi syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Toro C, Nicoli ER, Malicdan MC, Adams DR, Introne WJ, editors. GeneReviews((R)). Seattle (WA); 1993.
  • Van Gele M, Dynoodt P, Lambert J.Griscelli syndrome: a model system to study vesicular trafficking. Pigment Cell Melanoma Res. 2009;22(3):268–82. doi:10.1111/j.1755-148X.2009.00558.x.
  • Gargiulo A, Testa F, Rossi S, Di Iorio V, Fecarotta S, de Berardinis T, Iovine A, Magli A, Signorini S, Fazzi E, et al. Molecular and clinical characterization of albinism in a large cohort of Italian patients. Invest Ophthalmol Vis Sci. 2011;52(3):1281–89. doi:10.1167/iovs.10-6091.
  • Thomas MG, Kumar A, Mohammad S, Proudlock FA, Engle EC, Andrews C, Chan W-M, Thomas S, Gottlob I. Structural grading of foveal hypoplasia using spectral-domain optical coherence tomography a predictor of visual acuity? Ophthalmology. 2011;118(8):1653–60. doi:10.1016/j.ophtha.2011.01.028.
  • Fitzpatrick TB.The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124(6):869–71. doi:10.1001/archderm.1988.01670060015008.
  • Kruijt CC, de Wit GC, Talsma HE, Schalij-Delfos NE, van Genderen MM.The detection of misrouting in albinism: evaluation of different VEP procedures in a heterogeneous cohort. Invest Ophthalmol Vis Sci. 2019;60(12):3963–69. doi:10.1167/iovs.19-27364.
  • Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med Off J Am Coll Med Genet. 2015;17(5):405–24. doi:10.1038/gim.2015.30.
  • Gronskov K, Jespersgaard C, Bruun GH, Harris P, Brondum-Nielsen K, Andresen BS, Rosenberg T. A pathogenic haplotype, common in Europeans, causes autosomal recessive albinism and uncovers missing heritability in OCA1. Sci Rep. 2019;9(1):645. doi:10.1038/s41598-018-37272-5.
  • Lasseaux E, Plaisant C, Michaud V, Pennamen P, Trimouille A, Gaston L, Monfermé S, Lacombe D, Rooryck C, Morice-Picard F, et al. Molecular characterization of a series of 990 index patients with albinism. Pigment Cell Melanoma Res. 2018;31(4):466–74. doi:10.1111/pcmr.12688.
  • Hvid K, Nissen KR, Bayat A, Roos L, Gronskov K, Kessel L.Prevalence and causes of infantile nystagmus in a large population-based Danish cohort. Acta Ophthalmol. 2020;98(5):506–13. doi:10.1111/aos.14354.
  • Creel D, Giolli RA.Retinogeniculate projections in albino and ocularly hypopigmented rats. J Comp Neurol. 1976;166(4):445–55. doi:10.1002/cne.901660406.
  • Creel D, Spekreijse H, Reits D.Evoked potentials in albinos: efficacy of pattern stimuli in detecting misrouted optic fibers. Electroencephalogr Clin Neurophysiol. 1981;52(6):595–603. doi:10.1016/0013-4694(81)91433-4.
  • Lee H, Sheth V, Bibi M, Maconachie G, Patel A, McLean RJ, Michaelides M, Thomas MG, Proudlock FA, Gottlob I, et al. Potential of handheld optical coherence tomography to determine cause of infantile nystagmus in children by using foveal morphology. Ophthalmology. 2013;120(12):2714–24. doi:10.1016/j.ophtha.2013.07.018.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.